Christopher R Chitambar Selected Research

Christopher R Chitambar Research Topics

Disease

27	Neoplasms (Cancer) 10/2023 - 04/2003
13	Breast Neoplasms (Breast Cancer) 03/2024 - 11/2006
10	Lymphoma (Lymphomas) 07/2018 - 04/2003
7	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 04/2017
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 05/2004
5	Urinary Bladder Neoplasms (Bladder Cancer) 03/2013 - 04/2003
4	Pathologic Complete Response 01/2022 - 10/2002
3	Brain Neoplasms (Brain Tumor) 04/2020 - 04/2017
3	B-Cell Lymphoma (Lymphoma, B Cell) 03/2015 - 10/2002
2	Triple Negative Breast Neoplasms 01/2022 - 05/2019
2	Cardiotoxicity 05/2019 - 05/2002
2	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 04/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2003 - 12/2002
1	Overweight 05/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2024
1	COVID-19 12/2023
1	Glioma (Gliomas) 01/2022
1	Ductal Carcinoma 04/2020
1	Necrosis 04/2020
1	Osteosarcoma (Osteogenic Sarcoma) 07/2018
1	Leukemia 07/2018
1	Leukoencephalopathies 07/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2018
1	Carcinogenesis 12/2017
1	Rhabdoid Tumor (Rhabdoid Tumors) 04/2017
1	Medulloblastoma 04/2017
1	Fatigue 10/2016
1	Obesity 10/2016
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2007

Drug/Important Bio-Agent (IBA)

16	IronIBA 01/2023 - 05/2002
16	GalliumIBA 01/2018 - 04/2003
13	gallium nitrate FDA Link 01/2018 - 04/2003
10	MetalsIBA 01/2018 - 04/2003
9	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 11/2004
6	Hormones (Hormone)IBA 12/2023 - 04/2012
5	Proteins (Proteins, Gene)FDA Link 10/2023 - 02/2007
5	gallium maltolateIBA 01/2023 - 09/2007
5	Transferrin Receptors (Transferrin Receptor)IBA 01/2023 - 05/2004
5	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 04/2020 - 11/2004
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 05/2002
4	SaltsIBA 01/2018 - 04/2003
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2013
3	Methotrexate (Mexate)FDA LinkGeneric 12/2019 - 07/2002
3	Chelating AgentsIBA 05/2019 - 05/2002
3	Estrogen ReceptorsIBA 06/2018 - 04/2012
3	Transferrin (beta 2 Transferrin)IBA 01/2018 - 05/2004
3	Acid CeramidaseIBA 12/2017 - 04/2017
3	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 03/2013 - 04/2008
2	Trastuzumab (Herceptin)FDA Link 10/2023 - 04/2023
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 04/2020
2	Metformin (Glucophage)FDA LinkGeneric 04/2020 - 05/2019
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2018 - 06/2016
2	carmofurIBA 12/2017 - 04/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 10/2002
2	CalciumIBA 01/2010 - 04/2003
2	Rituximab (Mabthera)FDA Link 02/2004 - 10/2002
2	Vincristine (Oncovin)FDA LinkGeneric 10/2002 - 07/2002
1	Oxygen (Dioxygen)IBA 12/2023
1	Phosphotransferases (Kinase)IBA 04/2023
1	Tyrosine (L-Tyrosine)FDA Link 04/2023
1	ErbB Receptors (EGF Receptor)IBA 04/2023
1	metal transporting protein 1 (ferroportin)IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 03/2021
1	Keratin-18 (Keratin 18)IBA 04/2020
1	Deferasirox FDA Link 05/2019
1	Dexrazoxane (Zinecard)FDA LinkGeneric 05/2019
1	AntimetabolitesIBA 07/2018
1	RNA (Ribonucleic Acid)IBA 05/2018
1	ApoferritinsIBA 01/2018
1	Citric Acid (Citrate)FDA LinkGeneric 01/2018
1	Iron-Binding ProteinsIBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 12/2017
1	CytokinesIBA 03/2015
1	Coordination ComplexesIBA 03/2013
1	ThiosemicarbazonesIBA 03/2013
1	Estrogens (Estrogen)FDA Link 04/2012
1	Mitogen-Activated Protein KinasesIBA 04/2012
1	AnthracyclinesIBA 01/2012
1	Docetaxel (Taxotere)FDA Link 01/2012
1	Epirubicin (Ellence)FDA LinkGeneric 01/2012
1	taxaneIBA 01/2012
1	EnzymesIBA 01/2011
1	Bortezomib (Velcade)FDA Link 07/2010
1	Drug CombinationsIBA 07/2010
1	Heme Oxygenase-1IBA 09/2008
1	efalizumab (Raptiva)FDA Link 06/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2007

Therapy/Procedure

10	Therapeutics 10/2023 - 03/2013
6	Drug Therapy (Chemotherapy) 12/2023 - 10/2002
3	Neoadjuvant Therapy 01/2022 - 01/2012
2	Adjuvant Chemotherapy 09/2018 - 10/2016
1	Radiotherapy 03/2024
1	Length of Stay 12/2023
1	Treatment Delay 12/2023
1	Segmental Mastectomy (Lumpectomy) 06/2018
1	TEC protocol 01/2012
1	Combination Drug Therapy (Combination Chemotherapy) 07/2010